Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cayenne Medical

Cayenne Medical?uq=w9if130k
2005 FOUNDED
M&A STATUS
61-70 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Provider of arthroscopic surgery products. The company offers AperFix System that enables the surgeons to perform anterior cruciate ligament (ACL) reconstruction using the hamstring and various soft tissue grafts.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Medical Supplies
Acquirer
Primary Office
  • 16597 North 92nd Street
  • Suite 101
  • Scottsdale, AZ 85260
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cayenne Medical’s full profile, request a free trial.

Cayenne Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 16-May-2016 000.00 Completed Profitable
10. Debt - General 01-May-2015 0000 000.00 Completed Profitable
9. Later Stage VC (Series E) 13-Feb-2014 000 000.00 000.00 Completed Profitable
8. Later Stage VC 22-Jan-2014 00000 000.00 Completed Profitable
7. Debt - General 26-Jun-2012 000 000.00 Completed Profitable
6. Later Stage VC (Series D) 14-Feb-2012 000.00 000.00 000.00 Completed Profitable
5. Debt - General 31-Dec-2011 00.000 000.00 Completed Profitable
4. Later Stage VC 28-Jun-2010 00.000 000.00 Completed Profitable
3. Later Stage VC (Series C) 10-Mar-2008 $15M $31.3M 000.00 Completed Profitable
2. Early Stage VC (Series B) 13-Feb-2007 $12.8M $16.3M 0000 Completed Profitable
To view this company’s complete deal history including valuation and funding, request access »

Cayenne Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 0.000
Series D 00,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Series C 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Series B 5,683,334 $0.001000 $0.18 $2.25 $2.25 1x $2.25 11.26%
Series A 3,477,996 $0.001000 $0.1 $1.25 $1.25 1x $1.25 6.89%
To view this company’s complete Cap Table, request access »

Cayenne Medical Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bay Innovation Group Accelerator/Incubator Minority 000 0000 000000 0
Fletcher Spaght Ventures Venture Capital Minority 000 0000 000000 0
MB Venture Partners Venture Capital Minority 000 0000 000000 0
Patricia Industries PE/Buyout Minority 000 0000 000000 0
Pond Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Cayenne Medical Executive Team (15)

Name Title Board
Seat
Contact
Info
David Springer President & Chief Executive Officer
Tim Konkol Director of Operations
Eric Nordstrom Director of Sales, International
Kevin Tuller Director of Supply Chain Management
Kevin Nason Program Director

2 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

Cayenne Medical Board Members (7)

Name Representing Role Since Contact
Info
James Hart Cayenne Medical Executive Chairman & Co-Founder 000 0000

6 Former Board Members

You’re viewing 1 of 7 board members. Get the full list »